Talkspace, Inc.

Talkspace, Inc. (TALK) Market Cap

Talkspace, Inc. has a market capitalization of $874.4M.

Price: $5.22

0.01 (0.19%)

Market Cap: 874.42M

NASDAQ · time unavailable

CEO: Jon R. Cohen

Sector: Healthcare

Industry: Medical - Care Facilities

IPO Date: 2020-07-30

Website: https://www.talkspace.com

Talkspace, Inc. (TALK) - Company Information

Market Cap: 874.42M|Sector: Healthcare

Company Profile

Providing virtual behavioral healthcare services, Talkspace, Inc. operates a digital platform accessible via secure web and mobile applications. It offers a wide array of treatment options, including psychiatry, adolescent counseling, individual therapy, and support for couples. Clients can communicate with their dedicated therapists through various channels such as text, video, and voice messages, or by scheduling live video sessions. The company is based in New York, New York.

Analyst Sentiment

58%
Buy

From 8 Active Polls

1Y Forecast: $5.25

▲ +0.6% Potential Upside

Consensus Target Metrics

Low Bound

$5

Median

$5

High Bound

$5

Average

$5

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$5.25
▲ +0.57% Upside
Low Target
$5.25
1% Risk
Median Target
$5.25
1% Mid
High Target
$5.25
1% Max
Consensus
Hold
2 / 10 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)874872611465467432523352355
Enterprise Value ($M)843841574425413372446233240
Price to Earnings Ratio (P/E)1110.64-32.3832.0735.20-217.19336.84107.2947.07-187.50
Price/Earnings-to-Growth Ratio (PEG)5.263.77-53.2647.4038.5016.17-132.64
Price to Sales Ratio (P/S)3.6714.149.707.838.608.2710.737.437.71
Price to Book Ratio (P/B)7.787.725.224.264.143.814.452.993.11
Price to Free Cash Flow Ratio (P/FCF)-134.69-114.48293.94245.31-164.20-133.44217.3176.74116.69
Enterprise Value to Sales (EV/Sales)13.649.117.167.607.129.164.925.22
Enterprise Value to EBITDA (EV/EBITDA)136.03-182.6896.7092.231632.30341.03320.51114.73-1082.43
Debt to Equity Ratio-5.07

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 TALKSPACE INC (TALK) — Investment Overview

🧩 Business Model Overview

Talkspace operates a technology-enabled behavioral health services platform that connects members with licensed clinicians through remote care channels (e.g., messaging and video sessions). The value chain typically includes: (1) customer acquisition and eligibility/onboarding, (2) clinical matching and scheduling within a clinician network, (3) ongoing service delivery through an integrated digital experience, and (4) ongoing billing to consumers and/or payers depending on plan design.

A critical element of the model is “care continuity.” Once a member begins a therapy plan, the platform coordinates ongoing clinical interactions and typically retains the member within the same digital care environment, which increases the likelihood of sustained utilization relative to one-off episodes.

💰 Revenue Streams & Monetisation Model

Revenue is primarily driven by recurring subscriptions and care plans that bundle access to clinicians and asynchronous/virtual interactions. Monetisation also includes session-based components where pricing is tied to clinician utilization under defined plan terms.

Key margin drivers include:

  • Clinician cost structure vs. throughput: Gross margin depends on how efficiently clinician capacity is utilized per member and how much clinician time is required per retained user.
  • Payer and plan mix: Revenue quality improves when plans align with reimbursement frameworks and predictable utilization patterns.
  • Customer acquisition efficiency: Lifetime value is sensitive to marketing and onboarding costs relative to retention and session frequency.
  • Platform scalability: Incremental technology costs generally scale more efficiently than clinical labor, supporting operating leverage when utilization stabilizes.

🧠 Competitive Advantages & Market Positioning

The strongest structural advantage is switching costs driven by care continuity and digital care “data gravity.” Once members have an established clinical relationship, history, and treatment plan context within a platform, switching to a new provider can introduce friction (re-onboarding, clinical re-intake, care disruption) and often delays progress.

There is also a partial marketplace-style network effect: a larger and well-managed clinician network can support faster matching and more consistent availability, which improves member experience and retention—feeding back into higher demand quality.

However, unlike pure software subscriptions, Talkspace remains labor-dependent. This limits the extent to which margins can compress to software-like levels, but it does not eliminate the economic moats around member stickiness and operational execution.

Competitive benchmarking:

  • BetterHelp (LifeStance platform ecosystem): Competes in direct-to-consumer digital therapy. Talkspace’s differentiation tends to come from broader service configuration (including psychiatry pathways) and enterprise/payer relationships.
  • Teladoc Health / Amwell (telehealth incumbents): Compete across broader virtual health offerings. Their strength is distribution and embedded healthcare relationships, while Talkspace’s focus is behavioral health depth with a more specialized platform experience.
  • Lyra Health (employer mental health benefits): Emphasizes employer-sponsored benefits and care navigation. Talkspace competes through its digital-first care delivery and plan structures, while Lyra often competes on benefit administration and employer channel access.

Overall, Talkspace is best positioned as a specialized behavioral health platform where retention, clinical continuity, and clinician matching efficiency matter most—rather than as a broad general telehealth aggregator.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, durable growth drivers are anchored in secular adoption of remote behavioral healthcare and improving unit economics through operational learning:

  • TAM expansion from mental health access constraints: Provider shortages, long wait times, and geographic barriers continue to support tele-behavioral adoption.
  • Shift toward employer and payer-integrated care models: Health systems and employers increasingly seek measurable outcomes, programmatic care management, and scalable access—categories where a platform can differentiate.
  • Utilization optimization: Improved matching algorithms, scheduling workflows, and care-path design can increase throughput while maintaining clinical quality.
  • Broader modality coverage within behavioral health: Expanding the mix of therapy types and medication management pathways can increase engagement depth per member.
  • Data-informed care coordination: As members complete structured intakes and ongoing treatment interactions, the platform can improve clinical workflow standardization and reduce administrative burden.

⚠ Risk Factors to Monitor

  • Regulatory and licensure constraints: Telehealth rules and clinician licensing vary by jurisdiction, impacting service delivery and scalability.
  • Clinical quality and clinical liability: Behavioral health outcomes and patient safety are central; quality lapses can result in reputational and legal exposure.
  • Payer reimbursement and coverage dynamics: Changes in how tele-behavioral services are covered can affect plan design and utilization economics.
  • Clinician supply and scheduling reliability: If clinician availability tightens or matching becomes less efficient, retention and member experience can deteriorate.
  • Technology and privacy risk: Handling sensitive health information requires robust controls; breaches can create severe financial and operational consequences.
  • Competitive pricing pressure: Direct-to-consumer and employer-sponsored competitors can compress margins if acquisition costs rise or pricing becomes more promotional.

📊 Valuation & Market View

The market typically values digital health platforms on a revenue multiple basis (such as EV/Sales or P/S) and increasingly on qualitative progress toward durable unit economics rather than purely on subscriber counts. Because Talkspace’s model is partially labor-dependent, investors pay close attention to margin pathways and the sustainability of recurring revenue.

Drivers that tend to move valuation in this sector:

  • Evidence of operating leverage: Improvement in gross margin and contribution margin as utilization and retention stabilize.
  • Retention and engagement durability: Metrics that indicate members stay on-platform and complete care plans.
  • Acquisition efficiency: Lower customer acquisition cost per retained member and improved lifetime value capture.
  • Payer/enterprise revenue quality: Share of revenue tied to structured plans that support predictable utilization.

🔍 Investment Takeaway

Talkspace’s long-term investment case rests on whether it can convert tele-behavioral health adoption into sustained member retention and care continuity-driven switching costs, while scaling clinician matching and utilization to achieve consistent operating leverage. The competitive landscape includes specialized behavioral players and broader telehealth platforms, but Talkspace’s emphasis on behavioral health depth supports differentiation through durable engagement and platform stickiness—assuming regulatory compliance, clinical quality, and unit economics hold.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for TALK.

businesswire.com2026-06-09

Talkspace Announces ‘Tee,' the First Safe AI Agent Specifically Developed to Help Individuals Navigate Life's Daily Mental Health Challenges

NEW YORK--(BUSINESS WIRE)--Talkspace (NASDAQ: TALK), a leading online behavioral healthcare provider, today announced Tee, a safe, fine-tuned large language model developed by mental health experts. With HIPAA-grade privacy protections, Tee has the ability to identify potential suicide risk, homicidal/violence risk, abuse risk and seven other mental health risk entities. It is the first model of its kind providing real-time oversight by licensed clinicians and immediate human intervention by a.

globenewswire.com2026-06-02

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

As a Gold Sponsor of the Paris event, Enlivex will host a curated dinner today for leading institutional asset managers, allocators, and digital asset investors Nes-Ziona, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced that it is a Gold Sponsor of Proof of Talk 2026, taking place June 2-3, 2026, at the Louvre Palace and Musée des Arts Décoratifs in Paris.

globenewswire.com2026-05-29

Talkspace Stockholders Vote to Approve Acquisition by UHS

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Talkspace, Inc. (“Talkspace”) (Nasdaq: TALK) today announced that at the special meeting of Talkspace stockholders held on May 29, 2026, the Talkspace stockholders voted to approve the acquisition of Talkspace by Universal Health Services, Inc. (“UHS”) pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of March 9, 2026 (the “Merger Agreement”), by and among Talkspace, UHS and UHS Merger Subsidiary, Inc., an indirect wholly owned subsidiary of UHS.

businesswire.com2026-05-06

Talkspace Expands U.S. Navy Mental Health Support for Sailors and Families

NEW YORK--(BUSINESS WIRE)--Today Talkspace (NASDAQ: TALK) a leading online behavioral health care company, announced an expansion to its partnership with the U.S. Navy, reinforcing a shared commitment to enhance force readiness and strengthen family resilience. This expansion emphasizes early intervention and proactive support are key drivers of readiness. By equipping Sailors with tools to manage stress, build resilience and address challenges, Talkspace helps mitigate factors that can impact.

prnewswire.com2026-04-27

Health-E Commerce® Collaborates with Talkspace to Expand Mental Health Services Available on FSA Store® and HSA Store®

Individuals can use insurance and/or flexible spending account (FSA) and health savings account (HSA) funds to pay for virtual therapy with licensed providers; new patients save $100 when using tax-free FSA and HSA funds DALLAS, April 27, 2026 /PRNewswire/ -- Health-E Commerce ®, parent brand to FSA Store ® and HSA Store ®, the first and leading online stores dedicated to selling only products and services that are eligible with flexible spending account (FSA) and health savings account (HSA) funds, announced today a new telehealth collaboration with Talkspace that will allow individuals to use FSA and HSA funds to purchase virtual mental health counseling through FSA Store® and HSA Store®. First-time patients using FSA or HSA funds will receive $100 off Talkspace services.

businesswire.com2026-04-22

Americans Feel Increasingly Alone Despite Craving Connection, New Survey Finds

NEW YORK--(BUSINESS WIRE)--Many Americans say they want stronger connections in their lives but are also pulling back from relationships in ways that leave them feeling more disconnected, a new nationwide survey found. Commissioned by Talkspace and conducted by Talker Research, the survey of 2,000 U.S. adults identifies a ‘Disconnection Dilemma,' a growing trend where the desire for community is being undermined by increased rates of “going no-contact" as well as isolation to avoid difficult co.

defenseworld.net2026-03-23

Contrasting Azenta (NASDAQ:AZTA) & Talkspace (NASDAQ:TALK)

Talkspace (NASDAQ: TALK - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Analyst Recommendations This is a summary of current recommendations

globenewswire.com2026-03-17

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—ALIS, TALK, JTAI, and RLYB

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.

businesswire.com2026-03-10

Talkspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Talkspace, Inc. - TALK

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Talkspace, Inc. (NasdaqCM: TALK) to Universal Health Services, Inc. (NYSE: UHS). Under the terms of the proposed transaction, shareholders of Talkspace will receive $5.25 in cash for each share of Talkspace that they own. KSF is seeking to determine whether this consideration and the process that le.

247wallst.com2026-03-10

Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit

Four names are drawing analyst attention this week, with TD Cowen stepping back from Novo Nordisk A/S (NYSE:NVO), Truist trimming its target on Korn Ferry (NYSE:KFY), Morgan Stanley adjusting expectations for Jefferies Financial Group Inc.

247wallst.com2026-03-10

Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More

Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil futures, which shot up to $120 overnight, retreated below $100 on Monday. That was the biggest spike in oil pricing since 2020. With the retreat in the black gold, the major indices did a massive... Here Are Tuesday's Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims and Hers, Intuit, Lowe's, Qualcomm, Rivian, Strategy and More.

prnewswire.com2026-03-09

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Talkspace, Inc. (NASDAQ: TALK)

NEW YORK, March 9, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Talkspace, Inc. (NASDAQ: TALK ) related to its sale to Universal Health Services, Inc. Under the terms of the proposed transaction, Talkspace shareholders will be entitled to receive $5.25 per share in cash.

prnewswire.com2026-03-09

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.

prnewswire.com2026-03-09

Shareholder Alert: The Ademi Firm investigates whether Talkspace, Inc. is obtaining a Fair Price for its Public Shareholders

MILWAUKEE, March 9, 2026 /PRNewswire/ -- Ademi LLP is investigating Talkspace (NASDAQ: TALK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Universal Health Services. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

businesswire.com2026-03-09

TALK Stock Alert: Halper Sadeh LLC is Investigating Whether Talkspace, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Talkspace, Inc. (NASDAQ: TALK) to Universal Health Services, Inc. for $5.25 per share. Halper Sadeh encourages Talkspace shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Talkspace and its board of directors vio.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"TALK reported Q1’26 revenue of $61.68M and net income of -$6.31M (EPS -$0.04). Revenue was up +6.2% QoQ (vs. $62.998M in Q4’25) and +18.2% YoY (vs. $52.182M in Q1’25). Net income deteriorated sharply to -$6.31M from +$4.77M in Q4’25 and from +$0.32M in Q1’25 (YoY decline of -2,064% and QoQ decline of -232%). Profitability weakened materially: gross margin was 41.5% in Q1’26, slightly down vs. 42.7% in Q4’25 but roughly flat vs. 44.6% in Q1’25. Operating loss expanded to -$7.13M, with operating margin falling to -11.6% from +6.1% in Q4’25. Operating cash flow was -$4.42M and free cash flow also -$4.42M, indicating a near-term cash burn. Balance sheet remains debt-free with strong liquidity: cash & short-term investments were $84.21M at quarter-end and total assets were $136.19M, while total equity was $113.06M (equity base supported). There were no dividends or buybacks in the quarter. Total shareholder return is likely positive given the strong momentum: price is $5.18 with a +89.74% 1-year change."

Revenue Growth

Positive

Revenue grew +18.2% YoY (Q1’26 vs Q1’25) but was slightly down QoQ (about -2.1% vs Q4’25).

Profitability

Neutral

Net income swung to a loss (-$6.31M) from profit in both prior-year and prior-quarter comparisons; operating margin deteriorated to -11.6% from +6.1% in Q4’25.

Cash Flow Quality

Neutral

Operating cash flow and free cash flow were both negative in Q1’26 (-$4.42M). No dividend support or buyback activity observed.

Leverage & Balance Sheet

Positive

No debt (total debt $0). Liquidity remains solid with cash & short-term investments of $84.21M and equity of $113.06M.

Shareholder Returns

Positive

Strong 1-year price momentum (+89.74%) and no evidence of dividend yield; total return likely supported primarily by capital appreciation.

Analyst Sentiment & Valuation

Neutral

Consensus price target is $5.25 versus current $5.18 (limited upside). Profitability is currently weak, increasing valuation risk.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Management is broadly upbeat on momentum and visibility, pointing to Payor growth drivers (sessions +36.3% YoY; members +29.7% YoY) and strong cost discipline (operating expense ratio -660 bps; adjusted EBITDA +~500 bps margin YoY). Guidance reinforces this: 2026 revenue $275M-$290M and adjusted EBITDA $30M-$35M with mid-teens exit EBITDA margins. However, the Q&A shows the key “unknown” is adoption of the new TalkAI safe-mental-health agent. CEO Jon Cohen emphasized it is early beta work and he cannot yet say how users will migrate from general-purpose LLMs. The other operational vulnerability is seasonal: Q1 is expected to have the highest renewal attrition and sequential D2E weakness (DTE/Q4 implementation benefit won’t recur). Analyst pressure also focused on Medicare/MA cost pressures and utilization management; management leaned on outcomes-based contracts and value-based readiness but did not quantify impacts. Net: strong numbers, but execution and adoption uncertainties remain.

AI IconGrowth Catalysts

  • Payor session growth: 450,000 sessions in Q4 2025 (+36.3% YoY)
  • Payor active members growth: 124,000 unique active Payor members (+29.7% YoY)
  • Improved member journey/AI ops: reduced registration drop-offs; more patients continuing after first session
  • Talkcast engagement: users opening Talkcast between 1st and 2nd sessions are 20% more likely to complete 2nd and 3rd sessions
  • TalkAI (safe mental-health AI agent) beta testing; expected to be in market late Q2 (per CEO)

Business Development

  • Directory integrations with Payors (Q&A): line-of-sight for ~3 directory integrations in early 2026; described as similar or slightly larger opportunity vs 2025 integration
  • Wisdo acquisition: increased interest in Medicare Advantage (MA) plans
  • Partner example: Wisdo partnership with Novo Nordisk for GLP-1 group coaching (youth/GLP-1 category expansion)
  • Amazon Pharmacy integration (launched April 2025; Q4 remarks emphasize continued clinical/med workflow improvements)

AI IconFinancial Highlights

  • Total revenue Q4 2025: $63.0M (+29.3% YoY)
  • Payor revenue Q4 2025: $47.7M (+41% YoY)
  • Direct-to-enterprise (DTE) revenue Q4 2025: $11.6M (+21.8% YoY); DTE benefited from Wisdo acquisition implementation work (Wisdo closed Oct 1)
  • Consumer revenue Q4 2025: $3.7M (consistent with intentional prioritization of other channels)
  • Gross margin: 42.7% in Q4 2025, down 169 bps YoY (mix shift toward Payor)
  • Operating expenses as % of revenue: 36.7% in Q4, down 660 bps vs Q4 2024
  • Adjusted EBITDA Q4 2025: $6.6M (+147.1% YoY); adjusted EBITDA margin: 10.4% (+~500 bps YoY)
  • Cash: $92.6M at quarter end (down $25.2M YoY) driven by share repurchases ($17.2M in 2025) and Wisdo acquisition
  • 2026 guidance (initial): revenue $275M-$290M (+20% to +27% YoY)
  • 2026 adjusted EBITDA guidance: $30M-$35M (+90% to +122%); target implies exit 2026 EBITDA margins mid-teens (toward top of 12%-15% prior range)

AI IconCapital Funding

  • Share repurchases: $17.2M total in 2025 (full year)
  • Quarter-end cash: $92.6M; down $25.2M YoY largely due to buybacks and Wisdo acquisition

AI IconStrategy & Ops

  • Automation/AI in the member journey reduced friction: fewer registration drop-offs; improved scheduling/continuation after first session
  • Network management: curated psychiatry network to align clinician availability with utilization trends; psychiatry providers expanded to 400+
  • LLM channel traction: Q4 general purpose LLMs drove increasing % of traffic and checkouts
  • TalkAI commercialization path: beta testing in Q1/Q2 2026 timeframe with expectation to be in market late Q2

AI IconMarket Outlook

  • 2026 revenue cadence: first half ~<50% of annual revenue (vs active Payor member/sessions ramp throughout the year)
  • D2E: expected to grow in low single-digit % again; Q1 sequentially lower than Q4 due to highest renewal/attrition season
  • Payor revenue visibility: 30% to 50% of Payor revenue in early Jan 1 period coming from members already on-platform (not majority, but material)

AI IconRisks & Headwinds

  • LLM/TalkAI adoption uncertainty: CEO could not quantify yet what users will choose vs other general-purpose LLMs; movement in usage remains “work in progress” during beta
  • Gross margin pressure: Q4 gross margin down 169 bps YoY due to Payor mix shift (ongoing mix risk implied)
  • Seasonality/attrition risk: Q1 traditionally highest number of accounts up for renewal, leading to highest attrition; D2E expected to be sequentially lower in Q1 than Q4
  • Regulatory/partner environment risk (implied): Medicare Advantage/benefit cuts and reimbursement pressure were raised by analyst; management response emphasized comfort with outcomes-based model but did not provide quantitative mitigation

Sentiment: MIXED

Note: This summary was synthesized by AI from the TALK Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for TALK.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (TALK)

© 2026 Stock Market Info — Talkspace, Inc. (TALK) Financial Profile